Clinical trial NCT01489358 - References

Chikungunya Fever — Chikungunya Virus Vaccine Trial in Healthy Adults

Citation(s)

•   Powers AM, Logue CH
  Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol. 2007 Sep;88(Pt 9):2363-77. Review.
•   Strauss JH, Strauss EG
  The alphaviruses: gene expression, replication, and evolution. Microbiol Rev. 1994 Sep;58(3):491-562. Review. Erratum in: Microbiol Rev 1994 Dec;58(4):806.
•   Volk SM, Chen R, Tsetsarkin KA, Adams AP, Garcia TI, Sall AA, Nasar F, Schuh AJ, Holmes EC, Higgs S, Maharaj PD, Brault AC, Weaver SC
  Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol. 2010 Jul;84(13):6497-504. doi: 10.1128/JVI.01603-09. Epub 2010 Apr 21. Erratum in: J Virol. 2011 Jun;85(11):5706.

VRC 311: A Phase 1 Open Label, Dose-Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of a Virus-Like Particle (VLP) Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Details for clinical trial NCT01489358